Vantage | November 2022

Here are the latest updates on our portfolio companies across the Vertex network.

Vertex Ventures CN & Vertex Growth |「芯驰科技」E3高性能MCU正式量产出货！

自今年4月发布以来，芯驰科技克服疫情带来的各种困难和挑战。E3通过了AEC-Q100各项严格的可靠性测试，并于10月实现量产交付！

Vertex Ventures HC | Advice for Managing Downturns: Don't Panic

In these times I like to reference one of my favorite books — The Hitchhiker’s Guide to the Galaxy by Douglas Adams — because the phrase “Don’t Panic” is emblazoned on the cover of the Guide in large calming font. After the heady ride up in 2020 and 2021, the current downturn in public biotech indices, which are down between 30-40% (BTK or XBI) since their peak, has had a knock-on effect for private biotech companies trying to fundraise. With valuations decreasing and companies struggling to raise their next round of financing, it’s a good to heed those words and not panic.